Study of Silodosin to Facilitate Passage of Urinary Stones
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess if patients treated with silodosin will have a higher
spontaneous passage rate of their ureteral stone than those treated with placebo.